Switching from twice-daily abacavir and lamivudine to the once-daily fixed-dose combination tablet of abacavir and lamivudine improves patient adherence and satisfaction with therapy

✍ Scribed by D Maitland; A Jackson; J Osorio; S Mandalia; BG Gazzard; GJ Moyle; for the Epivir-Ziagen (EZ) Switch Study Team

• Book ID: 111063530
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 99 KB
• Volume: 9
• Category: Article
• ISSN: 1464-2662
• DOI: 10.1111/j.1468-1293.2008.00618.x